Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
Condition(s):Blood And Marrow Transplantation; Adult Respiratory Distress SyndromeLast Updated:April 10, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Blood And Marrow Transplantation; Adult Respiratory Distress SyndromeLast Updated:April 10, 2020Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:July 14, 2021Recruiting
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:April 10, 2019Completed
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:February 23, 2023Active, not recruiting
Condition(s):Acute Respiratory Distress SyndromeLast Updated:May 14, 2021Unknown status
Condition(s):ARDS, HumanLast Updated:May 6, 2023Not yet recruiting
Condition(s):Acute Respiratory Distress SyndromeLast Updated:January 31, 2017Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:August 14, 2017Completed
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:March 30, 2020Terminated
Condition(s):COVID-19 Acute Respiratory Distress SyndromeLast Updated:April 15, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.